| J9271 | Injection, pembrolizumab, 1 mg | 11,800 | $40 | $507.4K |
| J0897 | Injection, denosumab, 1 mg | 9,540 | $20 | $171.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,390 | $100 | $140.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 410 | $110 | $46.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 240 | $150 | $35.6K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 230 | $130 | $30.1K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 21,000 | $1 | $21K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 250 | $70 | $18.3K |
| 99491 | The provider, a physician or other healthcare professional, personally directs the evaluation and management of a patient with two or more chronic A physician or other qualified healthcare… | 200 | $70 | $13.7K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 1,870 | $10 | $11.2K |